Education
About Us
Working with TipRanks
Follow Us
Miranda Jayne Toledano Insider Profile
4 Followers
Miranda Jayne Toledano, EVP-Corporate Development at Sorrento Therapeutics, holds ― shares in Sorrento Therapeutics (Ticker: SRNE), holds 108.62K shares in Journey Medical Corp (Ticker: DERM), holds 415.57K shares in Entera Bio (Ticker: ENTX). Most recently, Miranda Jayne Toledano ― shares of Sorrento Therapeutics on ― for an estimated value of ―.
Miranda Jayne Toledano Sorrento Therapeutics (SRNE)EVP-Corporate Development
Sorrento Therapeutics (SRNE)
EVP-Corporate Development
Ranked #7,499 out of 103,606 Corporate Insiders
Profitable Transactions
3 out of 5 Profitable Transactions
Average Return
+56.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
A breakdown of Miranda Jayne Toledano's holdings
Insider Roles
Roles that Miranda Jayne Toledano holds in companies
Most Profitable Insider Trade
The most profitable trade made by Miranda Jayne Toledano
Miranda Jayne Toledano's Trading History
Sorrento Therapeutics
―
EVP-Corporate Development
―
―
Compass Therapeutics
Jun 29, 2021
Director
Uninformative Buy
―
$6.70M
NexGel Inc
Jan 03, 2022
Director
Informative Buy
9.99K
$4.37K
Entera Bio
Jul 18, 2025
CEO, Director
Uninformative Buy
―
$756.35K
Journey Medical Corp
Aug 07, 2025
Director
Uninformative Buy
―
$766.84K
List of latest transactions for each holding click on a transaction to see Miranda Jayne Toledano's performance on stock
You May Also Like
Miranda Jayne Toledano insider profile FAQ
What is the percentage of profitable transactions made by Miranda Jayne Toledano?
The percentage of profitable transactions made by Miranda Jayne Toledano is 60%.
What is the average return per transaction made by Miranda Jayne Toledano?
The average return per transaction made by Miranda Jayne Toledano is 56.40%.
What stocks does Miranda Jayne Toledano hold?
Miranda Jayne Toledano holds: SRNE, CMPX, NXGL, ENTX, DERM stocks.
What was Miranda Jayne Toledano’s latest transaction?
Miranda Jayne Toledano latest transaction was an Uninformative Buy of ―.
What was Miranda Jayne Toledano's most profitable transaction?
Miranda Jayne Toledano’s most profitable transaction was an Informative Buy of ENTX stock on December 27, 2023. The return on the trade was 241.20%.
What is Miranda Jayne Toledano's role in Sorrento Therapeutics?
Miranda Jayne Toledano's role in Sorrento Therapeutics is EVP-Corporate Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.